APPLICATION SITE MASS

This adverse event was reported 274 times

These drugs are most commonly taken by patients reporting APPLICATION SITE MASS:

# Drug Count
0 ESTRADIOL 38
1 PEGFILGRASTIM 35
2 EVOLOCUMAB 27
3 CLONIDINE TRANSDERMAL SYSTEM 10
4 CLONIDINE 9
5 LOSARTAN 9
6 DICLOFENAC SODIUM 8
7 NORELGESTROMIN AND ETHINYL ESTRADIOL 8
8 OCTREOTIDE ACETATE 8
9 GRANISETRON 7
See all common drugs associated with APPLICATION SITE MASS

APPLICATION SITE MASS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTAMINE 1 0.0069
1 CLONIDINE TRANSDERMAL SYSTEM 10 0.0047
2 NORELGESTROMIN AND ETHINYL ESTRADIOL 8 0.0043
3 SCOPOLAMINE TRANSDERMAL SYSTEM 1 0.0037
4 PEGFILGRASTIM 35 0.0029
5 DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM 1 0.0027
6 BALSALAZIDE DISODIUM 1 0.0019
7 BODY CLEANSER 1 0.0014
8 SELEGILINE 3 0.0010
9 PALONOSETRON HYDROCHLORIDE 5 0.0009
See all drugs enriched for association with APPLICATION SITE MASS

APPLICATION SITE MASS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 PCSK9 Inhibitor [EPC] 27 0.0010
2 Monoamine Oxidase Inhibitor [EPC] 3 0.0010
3 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 6 0.0007
4 Pyrethroid [EPC] 1 0.0006
5 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
6 GLP-2 Analog [EPC] 4 0.0003
7 Progesterone [EPC] 6 0.0003
8 Estrogen [EPC] 46 0.0002
9 Leukocyte Growth Factor [EPC] 35 0.0002
See all drug classes enriched for association with APPLICATION SITE MASS